• Thursday
  • October 2, 2014
  • Last updated: 12:51pm
Hong Kong

Humidity 

UV 

Pollution 

Refine Your Search

Sort by

Related Keywords

Search Results

Results 1 - 10 of 15 for drug

Search results

  1. Business - Companies - PHARMACEUTICALS

    Roche head says risks key to success

    Posted Sep 20th 2014, 05:10am by Reuters

    ... Schwan likes to crack open the champagne with his drug research teams at the end of a big project- especially when they fail. As the boss of one of the world's most successful pharmaceutical ... a failed experiment are an important component of Schwan's drive to encourage risk-taking in an intrinsically risky business, where nine out of 10 potential new drugs turn out to be flops. ...

    http://www.scmp.com/business/companies/article/1596347/roche-head-says-risks-key-success
  2. Business - Companies - PHARMACEUTICALS

    Samsung targets low cost drugs as its next growth driver

    Posted May 13th 2014, 01:13am by BLOOM

    ... Bloomberg in Tokyo South Korean electronics giant betting US$2b on biopharmaceuticals to shore up future growth Samsung targets low cost drugs as its next big thing Samsung Group transformed its electronics unit into the world's largest smartphone maker by outselling Apple. Now it is setting its sights on the drug industry. South Korea's biggest company is investing ...

    http://www.scmp.com/business/companies/article/1510759/samsung-targets-low-cost-drugs-its-next-growth-driver
  3. Business - China Business - PHARMACEUTICALS

    HK$785m goodwill writedown sees Wanjia record second-quarter loss

    Posted Aug 14th 2014, 02:16pm by Jasper Moiseiwitsch

    ... it took a hit of HK$785 million. In a profit warning earlier this month, the firm said the Fujian Food and Drug Administration had said in April that only selected distributors would be allowed ...

    http://www.scmp.com/business/china-business/article/1573480/hk785m-goodwill-writedown-sees-wanjia-record-second-quarter
  4. Business - Companies - PHARMACEUTICALS

    Drug firms suffer in China over GlaxoSmithKline bribery probe

    Posted Oct 24th 2013, 03:46am by Toh Han Shih

    ... Toh Han Shih hanshih.toh@scmp.com The British company says the mainland media has created a frenzy that has many buyers wary of dealing with multinational drug producers Sales plunge over GSK's bribery probe Sales of GlaxoSmithKline (GSK) and other drug firms have suffered from the mainland investigation of suspected corruption at the British firm and other drug multinationals, ...

    http://www.scmp.com/business/companies/article/1338300/drug-firms-suffer-china-over-glaxosmithkline-bribery-probe
  5. Business - China Business - PHARMACEUTICALS

    Drugmakers see safeguards in elevating Chinese executives

    Posted Jun 12th 2014, 01:10am by BLOOM

    ... a British national who previously led the group, helped set up and expand sales departments that offered bribes to doctors in return for prescribing drugs. We … have to learn how to make sure we ... divisions, reforms to the health system were needed to remove incentives for corruption, Bergstroem said. Some Chinese hospitals gained as much as half of their revenue from prescribing drugs ...

    http://www.scmp.com/business/china-business/article/1530410/drugmakers-see-safeguards-elevating-chinese-executives
  6. News - China - PHARMACEUTICALS

    Anti-graft probe hits shares of Chinese drug firm

    Posted Sep 12th 2013, 02:35pm by Toh Han Shih

    ... Toh Han Shih hanshih.toh@scmp.com Anti-graft probe hits shares of Chinese drug firm Shares in Hong Kong-listed Sino Biopharmaceutical plunged nearly 17 per cent yesterday on news that it had become the first major listed Chinese drug company to be probed in the central government's anti-corruption investigation of the pharmaceutical industry. In an announcement, Sino ...

    http://www.scmp.com/news/china/article/1308763/anti-graft-probe-hits-shares-chinese-drug-firm
  7. News - China - PHARMACEUTICALS

    China probes drug makers GSK, Merck over costs, possible price-fixing

    Posted Jul 04th 2013, 07:29pm by Reuters

    ... Top planning agency investigates foreign, Chinese drug makers over possible price-fixing China's top economic planning agency is investigating costs and prices charged by drug makers, ... already led to price cuts. The National Development and Reform Commission (NDRC) is surveying production costs and prices charged at multiple foreign and Chinese drug companies, according ...

    http://www.scmp.com/news/china/article/1275425/china-watchdog-probe-60-firms-over-drug-prices
  8. News - China - PHARMACEUTICALS

    Chinese government starts probe into maker of hepatitis B vaccine amid infant deaths

    Posted Dec 25th 2013, 05:38pm by AP

    ... Associated Press Beijing has sent health experts to investigate drug maker Biokangtai in Shenzhen on Tuesday, to find out if several recent deaths of babies were related to the company's vaccine. A team of government investigators was sent to the drug manufacturer, based in the southern city of Shenzhen, state broadcaster CCTV said, amid growing public concern about ...

    http://www.scmp.com/news/china/article/1389741/chinese-government-starts-probe-maker-hepatitis-b-vaccine-amid-infant
  9. Business - Companies - PHARMACEUTICALS

    GSK may face US charges over graft

    Posted Aug 09th 2013, 12:00am by Toh Han Shih

    ... Toh Han Shih hanshih.toh@scmp.com Lawyers say the British drug maker could pay record fine if prosecuted for alleged kickbacks to doctors and hospitals on the mainland GSK may face U.S. ... 3 billion yuan (HK$3.8 billion) in kickbacks to doctors, hospitals and other groups to prescribe its drugs. At least four senior Chinese GSK executives and 18 other employees of the company have ...

    http://www.scmp.com/business/companies/article/1295403/gsk-may-pay-high-price-us-settle-china-graft-allegations-say
  10. Business - Companies - PHARMACEUTICALS

    GSK to lift stake in India unit by US$1 b

    Posted Dec 17th 2013, 03:55am by Reuters

    ... of India's fast-growing US$13 billion drug market, but have been frustrated by a series of decisions on intellectual property and pricing. In August, India revoked a patent granted to GSK for its breast-cancer drug Tykerb, a decision that followed a landmark court ruling disallowing patents for incremental innovations that was a blow to global pharmaceutical firms. Despite the challenges, ...

    http://www.scmp.com/business/companies/article/1383001/gsk-lift-stake-india-unit-us1-b

Pages

Login

SCMP.com Account

or